Heidi Lyng Awarded ESTRO Interdisciplinary Prize for 2026
The prestigious interdisciplinary prize from the European Society for Radiotherapy and Oncology (ESTRO) honors outstanding research and significant contributions across disciplines within radiation oncology. The award highlights both the high quality of the research environment and the importance of interdisciplinary collaboration in the development of future cancer treatments.
This year, the prize was given to Heidi Lyng, head of the Clinical Radiation Biology group at the Institute for Cancer Research, for her work to understand the radiobiology of patient tumors and translate this knowledge into clinical practice.
Through the creation of multiprofessional teams, Lyng has demonstrated how advanced analytical approaches can be applied to improve diagnostics and enable more personalized treatment. Her work is built on a strong collaborative radiotherapy research environment in Norway and internationally.
The prize was presented at the annual ESTRO conference in Stockholm in May.
Links:
Heidi Lyng's research group OUS - Clinical Radiation Biology (Lyng)